Characteristics of the study population*
| Overall, n (%), (N=339 772) | |
| Age in years | 58.6±16.7 |
| Sex | |
| Female | 53 945 (15.9) |
| Male | 285 827 (84.1) |
| Race/ethnicity | |
| American Indian/Native Alaskan | 2899 (0.9) |
| Asian | 3169 (0.9) |
| Black/African American | 68 784 (20.2) |
| Native Hawaiian/Pacific Islander | 3086 (0.9) |
| Unknown | 45 795 (13.5) |
| White | 216 039 (63.6) |
| Hispanic or Latino | 30 472 (9.0) |
| Veterans | 325 428 (95.8) |
| Supplemental oxygen | 2421 (0.7) |
| Full vaccinated≥14 days from COVID-19 diagnosis | 30 817 (9.1) |
| Median interval between vaccination and diagnosis (days) | 154 |
| Injections after 1 July 2021 | 73 117 (21.5) |
| Death within 60 days of diagnosis | 18 120 (5.3) |
*A total of 339 772 individuals out of 347 220 had pre-existing conditions.